Lisa Bodei

Lisa Bodei

Memorial Sloan Kettering Cancer Center - Indore / United States
Medical and Health Sciences / Nuclear Medicine
AD Scientific Index ID: 4441141
person_outline Lisa Bodei's MOST POPULAR ARTICLES
1-) The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumoursJJ Zaknun, L Bodei, J Mueller-Brand, ME Pavel, RP Baum, D Hörsch, ...European journal of nuclear medicine and molecular imaging 40 (5), 800-816, 20136972013
2-) Radiopharmaceutical therapy in cancer: clinical advances and challengesG Sgouros, L Bodei, MR McDevitt, JR NedrowNature reviews Drug discovery 19 (9), 589-608, 20205812020
3-) Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogsDJ Kwekkeboom, J Mueller-Brand, G Paganelli, LB Anthony, S Pauwels, ...Journal of Nuclear Medicine 46 (1 suppl), 62S-66S, 20055582005
4-) Peptide receptor radionuclide therapy with 177Lu-DOTATATE: the IEO phase I-II studyL Bodei, M Cremonesi, CM Grana, N Fazio, S Iodice, SM Baio, ...European journal of nuclear medicine and molecular imaging 38, 2125-2135, 20114932011
5-) Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factorsL Bodei, M Cremonesi, M Ferrari, M Pacifici, CM Grana, M Bartolomei, ...European journal of nuclear medicine and molecular imaging 35, 1847-1856, 20084892008